DiaPep-277

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameDiaPep-277
Drug Alias NamePeptide P277DiaPep-277
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionToll like receptor 2 antagonists
TargetsToll like receptor 2
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSouth AfricaItaly +[11] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAndromeda Biotech Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A